Wayspring announced today its new name and a $75 million investment from Valtruis, Centene Corporation, CareSource, HLM Venture Partners, and other leading investors. Wayspring will use the capital to scale its value-based care solution, a full-risk medical home model for substance use disorder (SUD).

The funding also includes existing investors Highmark Ventures, .406 Ventures, the Blue Venture Fund, and Oak HC/FT.

Wayspring is a value-based care entity exclusively focused on substance use disorder. The company leverages data analytics to outreach to the highest-risk individuals and deliver high-touch, community-based peer support, behavioral health, and primary care. Wayspring also partners with existing provider networks to refer members to high-quality treatment, facilitate care transitions, and improve adherence to evidence-based medicine. For more information, visit www.wayspring.com.